Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

orifarm generics a/s - glucosaminsulfat natriumchlorid - filmovertrukne tabletter - 1500 mg

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

blue bio pharmaceuticals ltd. - glucosaminsulfat natriumchlorid - filmovertrukne tabletter - 1,178 mg

Den Europæiske Union - dansk - EMA (European Medicines Agency)

extrovis eu ltd. - lacosamid - epilepsi - antiepileptika, - lacosamide adroiq is indicated as monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 2 years of age with epilepsy. lacosamide adroiq is indicated as adjunctive therapyin the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 2 years of age with epilepsy. in the treatment of primary generalised tonic-clonic seizures in adults, adolescents and children from 4 years of age with idiopathic generalised epilepsy.

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

stada arzneimittel ag - lacosamid - filmovertrukne tabletter - 50 mg

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

krka d.d. novo mesto - lacosamid - filmovertrukne tabletter - 50 mg

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

zentiva k.s. - lacosamid - filmovertrukne tabletter - 50 mg

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

blue bio pharmaceuticals ltd. - glucosaminsulfat natriumchlorid - filmovertrukne tabletter - 393 mg

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

stada arzneimittel ag - lacosamid - filmovertrukne tabletter - 100 mg

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

stada arzneimittel ag - lacosamid - filmovertrukne tabletter - 150 mg

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

stada arzneimittel ag - lacosamid - filmovertrukne tabletter - 200 mg